https://openbell.ai/ 2026-09-30T12:53:58.434Z hourly 1.0 https://openbell.ai/support 2026-09-30T12:53:58.434Z monthly 0.7 https://openbell.ai/privacy 2026-09-30T12:53:58.434Z monthly 0.5 https://openbell.ai/terms 2026-09-30T12:53:58.434Z monthly 0.5 https://openbell.ai/feed.json 2026-09-30T12:53:58.434Z hourly 0.8 https://openbell.ai/news/WTE:1790772826623 2026-09-30T12:53:46.623Z daily 0.9 https://cdn.brandfetch.io/WTE/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Westshore Terminals, Raises Price Target to C$47 RBC Capital analyst Walter Spracklin has maintained an Outperform rating on Westshore Terminals (TSX: WTE) and increased the price target from C$44 to C$47. https://openbell.ai/news/KMX:1790772526651 2026-09-30T12:48:46.651Z daily 0.9 https://cdn.brandfetch.io/KMX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Baird Maintains Outperform on CarMax, Raises Price Target to $70 Baird analyst Craig Kennison has maintained an Outperform rating on CarMax (NYSE: KMX) and increased the price target from $64 to $70. This adjustment reflects positive expectations for the company's performance in the market. https://openbell.ai/news/MTL:1790772382601 2026-09-30T12:46:22.601Z daily 0.9 https://cdn.brandfetch.io/MTL/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Mullen Group, Raises Price Target to C$32 RBC Capital analyst Walter Spracklin has maintained an 'Outperform' rating on Mullen Group (TSX: MTL) and increased the price target from C$30 to C$32. This adjustment reflects a positive outlook for the company. https://openbell.ai/news/QCLS:1790772373918 2026-09-30T12:46:13.918Z daily 0.9 https://cdn.brandfetch.io/QCLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Q/C Technologies Announces Research Collaboration With Sandia National Laboratories On Optical Chips For AI Inference openbell Financial News https://openbell.ai/news/CALM:1790772363190 2026-09-30T12:46:03.190Z daily 0.9 https://cdn.brandfetch.io/CALM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cal-Maine Foods shares are trading lower after the company reported worse-than-expected Q1 financial results. openbell Financial News https://openbell.ai/news/FBK:1790772326022 2026-09-30T12:45:26.022Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Crypto-Trader-Investor-Broker-Using-Smar.jpg?width=250&height=187 FB Financial Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call FB Financial Corporation (NYSE: FBK) is set to release its third-quarter earnings report on October 13, with analysts predicting earnings of $1.21 per share, an increase from $1.07 per share in the previous year, and quarterly revenue of $181.55 million, up from $173.88 million last year. The company recently completed a $125 million subordinated notes offering due in 2036. FBK shares declined by 0.7% to close at $51.89 on Tuesday. https://openbell.ai/news/TT:1790772235058 2026-09-30T12:43:55.058Z daily 0.9 https://cdn.brandfetch.io/TT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trane Technologies Demonstrates First 800-Volt DC Cooling Architecture Trane Technologies (NYSE: TT) has successfully demonstrated the industry's first 800-volt direct current (800 VDC) cooling architecture, aimed at meeting the energy and thermal needs of next-generation AI factories and gigawatt-scale data centers. This proof-of-concept, validated on a high-efficiency chiller platform, showcases the performance and efficiency benefits of direct current power distribution in critical cooling applications. https://openbell.ai/news/CRL:1790772139450 2026-09-30T12:42:19.450Z daily 0.9 https://cdn.brandfetch.io/CRL/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Reinstates Buy on Charles River, Announces $357 Price Target UBS analyst Kevin Caliendo has reinstated a Buy rating on Charles River Laboratories (NYSE: CRL) and set a price target of $357 for the stock. This recommendation indicates a positive outlook for the company's performance in the market. https://openbell.ai/news/NUR:1790772039917 2026-09-30T12:40:39.917Z daily 0.9 https://cdn.brandfetch.io/NUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud NuRAN Wireless To Test Starlink Low Earth Orbit Satellite Backhaul In Nigeria With Infratel Africa NuRAN Wireless Inc. (Nasdaq: NUR) is initiating a pilot project in Nigeria to test licensed Starlink low Earth orbit satellite backhaul in collaboration with Infratel Africa Limited. The pilot aims to evaluate the throughput, reliability, and cost-effectiveness of the satellite backhaul to enhance operator traffic and support future digital services. https://openbell.ai/news/ERNA:1790772023857 2026-09-30T12:40:23.857Z daily 0.9 https://cdn.brandfetch.io/ERNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ernexa Therapeutics Announces Encouraging Results From Three Core IND-Enabling Safety Studies Of ERNA-101, Lead Synthetic, Allogeneic iMSC Therapy Engineered To Express IL-7/IL-15 Fusion Cytokine Ernexa Therapeutics announced positive results from three core IND-enabling safety studies of its lead therapy, ERNA-101, which is designed to treat advanced cancers. The studies showed no adverse findings in a repeat-dose GLP toxicology study, no teratoma formation in a six-month tumorigenicity study, and no significant signal in tumor-free animals during the biodistribution study. These results support the safety profile of ERNA-101 as the company prepares for a planned IND submission in Q4 2026, following successful preclinical efficacy data in ovarian cancer models. https://openbell.ai/news/BTCUSD:1790772006759 2026-09-30T12:40:06.759Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/2-Bitcoin-tokens-flank-a-bar-of-gold.jpg?width=250&height=187 Bitcoin 'Debasement Trade' Gains Steam Again as Institutions Pile In Institutional investors are increasingly viewing Bitcoin (BTC) as a hard asset alongside gold, with interest noted from several sovereign wealth funds. Notably, one fund was reported to be selling gold and foreign exchange reserves to finance Bitcoin purchases. During Bitcoin's recent bear market, institutions did not sell their holdings, with some even increasing their investments, reflecting a growing belief in Bitcoin as a hedge against currency debasement. Recent inflows of $2.5 billion into spot Bitcoin ETFs indicate strong institutional demand, suggesting a shift towards Bitcoin becoming a standard part of institutional portfolios. https://openbell.ai/news/NUR:1790772006736 2026-09-30T12:40:06.736Z daily 0.9 https://cdn.brandfetch.io/NUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud NuRAN Wireless To Test Starlink Low Earth Orbit Satellite Backhaul In Nigeria With Infratel Africa NuRAN Wireless Inc. is conducting a pilot test of licensed Starlink low Earth orbit satellite backhaul in Nigeria in collaboration with Infratel Africa Limited. This initiative aims to evaluate the throughput, reliability, and economic viability necessary for handling increased operator traffic and supporting additional digital services in the region. https://openbell.ai/news/NAGE:1790771951006 2026-09-30T12:39:11.006Z daily 0.9 https://cdn.brandfetch.io/NAGE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Niagen Bioscience Enters Start-Up Agreement With Mass General Brigham To Plan The Largest And Most Comprehensive Clinical Trial Of Niagen To Date Niagen Bioscience has entered a start-up agreement with Mass General Brigham (MGB) to conduct the largest clinical trial of Niagen to date, focusing on its effects on aging outcomes in healthy adults aged 50 and older. The trial will be a prospective, randomized, placebo-controlled study evaluating various health and wellness metrics, including biomarkers related to biological aging. The initiative aims to attract additional collaborators from academic, nonprofit, and industry sectors to enhance the trial's planning and execution. Niagen has a strong history of supporting over 175 ongoing research studies and has published more than 45 peer-reviewed clinical studies. https://openbell.ai/news/CLIR:1790771943046 2026-09-30T12:39:03.046Z daily 0.9 https://cdn.brandfetch.io/CLIR/w/400/h/400?c=1idopYfmtR7ZKg8QMud US DOE Industrial Technologies Office Selects ClearSign And Kern Energy For Its Industrial Technology Validation Program ClearSign Technologies Corporation (NASDAQ: CLIR) and Kern Energy have been selected by the U.S. Department of Energy's Industrial Technologies Office for its Industrial Technology Validation program. The initiative aims to demonstrate ClearSign's Core™ Gen 2 Flex Fuel Process Burner, which is designed to reduce emissions and energy costs at Kern Energy's facility. This collaboration highlights ClearSign's commitment to advancing cleaner fuel technologies. https://openbell.ai/news/BATL:1790771907641 2026-09-30T12:38:27.641Z daily 0.9 https://cdn.brandfetch.io/BATL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Battalion Oil Says It Is In Early-Stage Data Center, Power Generation Talks With Developers, Hyperscalers For 3,000+ Texas Acres Battalion Oil is currently in early-stage discussions with developers and hyperscalers regarding the development of a data center and power generation project on over 3,000 acres in Texas. The company aims to leverage its land assets for potential growth in the energy sector. Further details on financial implications or timelines were not disclosed. https://openbell.ai/news/BATL:1790771887940 2026-09-30T12:38:07.940Z daily 0.9 https://cdn.brandfetch.io/BATL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Battalion Oil Sees FY2027 EBITDA $75M-$85M, Production 14.0-15.0 MBoe/d, Assuming ATM Funding; FY2026 EBITDA $44M-$48M Battalion Oil projects FY2027 EBITDA between $75 million and $85 million, with production expected to reach 14.0 to 15.0 MBoe/d, contingent on At-the-Market (ATM) funding. For FY2026, the company anticipates EBITDA of $44 million to $48 million. https://openbell.ai/news/SRPT:1790771881676 2026-09-30T12:38:01.676Z daily 0.9 https://cdn.brandfetch.io/SRPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sarepta Therapeutics Presents New Data At 31st Annual Congress Of WMS That Provide Evidence Of Clinically Meaningful Functional Benefit Of ELEVIDYS In Older Ambulatory Patients With Duchenne Muscular Dystrophy Sarepta Therapeutics presented new data at the 31st Annual Congress of the World Muscle Society, demonstrating clinically meaningful benefits of its treatment ELEVIDYS (delandistrogene moxeparvovec) in older ambulatory patients with Duchenne muscular dystrophy. Patients aged 8-12 showed durable improvements over two years compared to a matched control group, while younger patients (ages 2-3) exhibited strong dystrophin expression 12 weeks post-infusion. The safety profile of the treatment remained consistent, with no new safety signals identified. https://openbell.ai/news/ELMT:1790771871852 2026-09-30T12:37:51.852Z daily 0.9 https://cdn.brandfetch.io/ELMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Elmet Technologies' Subsidiary Receives ~$36M Contract From Defense Logistics Agency To Provide Molybdenum And Tungsten Alloys And Precision Wire To U.S. National Defense Stockpile Elmet Technologies, a subsidiary of The Elmet Group Co. (NASDAQ: ELMT), has secured a contract worth approximately $36 million from the Defense Logistics Agency to supply molybdenum and tungsten alloys and precision wire for the U.S. National Defense Stockpile. These materials are critical for manufacturing jet engine components and other aerospace applications. This contract is distinct from a previously announced $2 billion DLA contract on September 14, 2026. https://openbell.ai/news/TD:1790771846501 2026-09-30T12:37:26.501Z daily 0.9 https://cdn.brandfetch.io/TD/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Bank Announces New C$10B Stock Buyback Program Not To Exceed 61M Shares; Intends To Complete Buyback By July 2027 TD Bank has announced a new C$10 billion stock buyback program, which will not exceed 61 million shares, and aims to complete the buyback by July 2027. This follows the completion of a previous repurchase of C$7 billion, involving 47.2 million shares, under its existing normal course issuer bid (NCIB) that began in January 2026. The new buyback will represent up to 3.74% of the Bank's total outstanding shares as of August 31, 2026, and all purchased shares will be cancelled. https://openbell.ai/news/SKYX:1790771825666 2026-09-30T12:37:05.666Z daily 0.9 https://cdn.brandfetch.io/SKYX/w/400/h/400?c=1idopYfmtR7ZKg8QMud SKYX Platforms Agrees To Supply Patented Safe Advanced And Smart Home Technologies To Trump Towers Hyderabad, India SKYX Platforms Corp. has signed an agreement to provide its patented safe advanced and smart home technologies for Trump Towers Hyderabad, a luxury residential development in India. The project, developed by IRA Realty and Tribeca Developers, will feature two 65-storey towers connected by a suspended sky bridge and will include over 450 residences. This development represents a significant expansion of SKYX's technology application in international markets. https://openbell.ai/news/OSIS:1790771815897 2026-09-30T12:36:55.897Z daily 0.9 https://cdn.brandfetch.io/OSIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud OSI Systems Awarded ~$23M Orders From Undisclosed North American Client For Its Civil Works, Service, And Support For Its Cargo Inspection Systems OSI Systems, Inc. (NASDAQ: OSIS) has announced that its Security division received orders worth approximately $23 million from an undisclosed North American client. The orders are for civil works, service, and support related to its cargo inspection systems. https://openbell.ai/news/PSX:1790771746390 2026-09-30T12:35:46.390Z daily 0.9 https://cdn.brandfetch.io/PSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Phillips 66, Raises Price Target to $295 TD Cowen analyst Jason Gabelman has maintained a 'Buy' rating on Phillips 66 (NYSE: PSX) and increased the price target from $255 to $295. https://openbell.ai/news/LNTH:1790771726341 2026-09-30T12:35:26.341Z daily 0.9 https://cdn.brandfetch.io/LNTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lantheus Receives Transitional Pass-Through Payment Status For PYLARIFY TruVu Injection From Centers For Medicare & Medicaid Services, Effective Oct. 1 Lantheus Holdings, Inc. (NASDAQ: LNTH) has received Transitional Pass-Through payment status from the Centers for Medicare & Medicaid Services for its PYLARIFY TruVu injection, effective October 1, 2026. This designation allows for separate reimbursement in the hospital outpatient setting, aimed at improving access to innovative diagnostic radiopharmaceuticals for Medicare beneficiaries. https://openbell.ai/news/UTZ:1790771707233 2026-09-30T12:35:07.233Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Defensive-Stocks-Puzzle-Utilities-Health.jpg?width=250&height=187 Top 3 Risk Off Stocks That May Fall Off A Cliff This Month As of September 30, 2026, three consumer staples stocks are identified as potentially overbought: Utz Brands Inc (NYSE: UTZ), AVAX One Technology Ltd (NASDAQ: AVX), and Bonk Inc (NASDAQ: BNKK). Utz Brands announced a quarterly cash dividend of approximately $0.063 per share, with a stock price of $14.25 and an RSI of 74.9. AVAX One Technology authorized a $40 million buyback program, with shares closing at $6.79 and an RSI of 81.9, while Bonk Inc entered a redemption agreement to retire shares for $4 million, closing at $2.01 with an RSI of 73.1. https://openbell.ai/news/ONDS:1790771595297 2026-09-30T12:33:15.297Z daily 0.9 https://cdn.brandfetch.io/ONDS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ondas Announces Launch Of Long-Range Dronebuster REACH Counter-Drone System; First Unit Under Contract With Office Of Naval Research openbell Financial News https://openbell.ai/news/MDT:1790771588883 2026-09-30T12:33:08.883Z daily 0.9 https://cdn.brandfetch.io/MDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Reiterates Buy on Medtronic, Maintains $110 Price Target TD Cowen analyst Joshua Jennings has reiterated a 'Buy' rating on Medtronic (NYSE: MDT) and maintained a price target of $110 for the stock. This endorsement reflects confidence in the company's performance and potential for growth. https://openbell.ai/news/CADL:1790771581736 2026-09-30T12:33:01.736Z daily 0.9 https://cdn.brandfetch.io/CADL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Candel Therapeutics Announces Immunological Biomarker Data From Ongoing Phase 2 Prtk05 Trial In Patients With Intermediate-Risk Localized Prostate Cancer Candel Therapeutics, Inc. announced novel immunological biomarker data from its ongoing Phase 2 PrTK05 trial for patients with intermediate-risk localized prostate cancer, showing T-cell activation and evidence of persistent local immune remodeling. The company plans to include biodistribution and shedding data from this trial in its Biologics License Application (BLA) submission to the FDA, expected in Q4 2026. The intermediate-risk prostate cancer patient population represents a significant market, with approximately 65,000 patients treated annually in the U.S. https://openbell.ai/news/TNON:1790771573878 2026-09-30T12:32:53.878Z daily 0.9 https://cdn.brandfetch.io/TNON/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tenon Medical Commercially Rolls Out Its New Titanium 3D-Printed Lateral Screw Tenon Medical, Inc. (NASDAQ: TNON) has announced the full commercial launch of its new titanium 3D-printed lateral screw, part of the SImmetry+ SI Joint Fusion System, following a successful Alpha launch. The Alpha launch generated approximately $1.2 million in incremental revenue from late Q4 2025 through Q3 2026. To meet anticipated demand, the company plans to expand its instrument set inventory. https://openbell.ai/news/AMIX:1790771529747 2026-09-30T12:32:09.747Z daily 0.9 https://cdn.brandfetch.io/AMIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform Autonomix Medical, Inc. (NASDAQ: AMIX) has successfully completed a pre-submission meeting with the FDA for its standalone transvascular sensing platform, which aims to detect faint biological signals. The meeting provided guidance on the regulatory strategy and validation activities, with the company identifying a Class II regulatory pathway using a cleared reference device. If development and validation are successful, Autonomix is targeting potential U.S. clearance in approximately 15 months. https://openbell.ai/news/FBDT:1790771527795 2026-09-30T12:32:07.795Z daily 0.9 https://cdn.brandfetch.io/FBDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud First Breach Announces 110% Increase In Ammunition Plant Hours To 84 Per Week, Plans Move To 24-Hour Operations openbell Financial News https://openbell.ai/news/MU:1790771462162 2026-09-30T12:31:02.162Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $MU Main sentiment: Neutral Key theme/event: Discussion on the attractiveness of stocks versus 30-year Treasury yields, with mixed opinions on their comparability and performance. https://openbell.ai/news/SPY:1790771461444 2026-09-30T12:31:01.444Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $SPY The $100 Challenge continues on Day 2 across multiple subreddits, with participants expressing optimism about recovering losses. The overall sentiment remains bullish as users encourage each other to stay engaged in the challenge. https://openbell.ai/news/MDB:1790771447279 2026-09-30T12:30:47.279Z daily 0.9 https://cdn.brandfetch.io/MDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Reiterates Buy on MongoDB, Maintains $560 Price Target Guggenheim analyst Howard Ma has reiterated a Buy rating on MongoDB (NASDAQ: MDB) and maintained a price target of $560 for the stock. This endorsement suggests continued confidence in the company's performance and growth potential. https://openbell.ai/news/SPY:1790771426699 2026-09-30T12:30:26.699Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Core PCE Price Index (YoY) For Aug. 3.0% Vs 3.3% Est. openbell Financial News https://openbell.ai/news/SPY:1790771411774 2026-09-30T12:30:11.774Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud GDP QoQ 2.2% Vs 1.5% Expected openbell Financial News https://openbell.ai/news/BWXT:1790771384685 2026-09-30T12:29:44.685Z daily 0.9 https://cdn.brandfetch.io/BWXT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Reiterates Buy on BWX Technologies, Maintains $192 Price Target Guggenheim analyst Michael Ciarmoli has reiterated a Buy rating on BWX Technologies (NYSE: BWXT) and has maintained a price target of $192 for the stock. This endorsement reflects confidence in the company's performance and potential for growth. https://openbell.ai/news/NEOG:1790771310615 2026-09-30T12:28:30.615Z daily 0.9 https://cdn.brandfetch.io/NEOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Neogen, Raises Price Target to $14 Guggenheim analyst Subbu Nambi has maintained a 'Buy' rating on Neogen (NASDAQ: NEOG) and raised the price target from $12 to $14. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/ZBIO:1790771187669 2026-09-30T12:26:27.669Z daily 0.9 https://cdn.brandfetch.io/ZBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Reiterates Outperform on Zenas BioPharma, Maintains $45 Price Target Wedbush analyst Martin Fan has reiterated an 'Outperform' rating on Zenas BioPharma (NASDAQ: ZBIO) and maintained a price target of $45 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://openbell.ai/news/RCT:1790770971436 2026-09-30T12:22:51.436Z daily 0.9 https://cdn.brandfetch.io/RCT/w/400/h/400?c=1idopYfmtR7ZKg8QMud RedCloud Enters 20-Year Platform License And Infrastructure Use Agreement And JV With Saudi Firm MJM AlKhaleej To Deploy Its RedAI Intelligent Trade Infrastructure In Saudi Arabia And Bahrain On September 27, 2026, RedCloud Holdings plc and its subsidiary entered into a 20-year platform license and infrastructure usage agreement with Saudi firm MJM AlKhaleej to establish a joint venture for deploying RedCloud's RedAI intelligent trade infrastructure in Saudi Arabia and Bahrain. The joint venture will have a 51% ownership by RedCloud UK and 49% by MJM, leveraging RedCloud's technology and MJM's market access. The Licensing Agreement allows RedCloud UK to provide AI infrastructure and services, with charges capped at 10% of eligible collected revenue per customer order. https://openbell.ai/news/ALTO:1790770965827 2026-09-30T12:22:45.827Z daily 0.9 https://cdn.brandfetch.io/ALTO/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Initiates Coverage On Alto Ingredients with Buy Rating, Announces Price Target of $7 StoneX analyst Ben Klieve has initiated coverage on Alto Ingredients (NASDAQ: ALTO) with a Buy rating. The analyst has set a price target of $7 for the company's stock. https://openbell.ai/news/AIB:1790770812989 2026-09-30T12:20:12.989Z daily 0.9 https://cdn.brandfetch.io/AIB/w/400/h/400?c=1idopYfmtR7ZKg8QMud AIB Data Centers Inks Agreement With Nebius For 50 Megawatts Of IT Capacity At Its U.S. Site AIB Data Centers Inc. has signed a binding agreement with Nebius for 50 megawatts of IT capacity at its U.S. facility. The deal, which spans an initial 12-year term, is expected to be funded through customer prepayments, project-level debt, and preferred equity, thereby minimizing the need for corporate-level common equity and reducing potential shareholder dilution. https://openbell.ai/news/NBIS:1790770794504 2026-09-30T12:19:54.504Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Nebius-Group.jpg?width=250&height=187 What's Going on With Nebius Stock on Wednesday? Nebius Group N.V. (NASDAQ: NBIS) shares rose 1.75% to $241.50 in premarket trading on Wednesday, driven by positive sentiment in the AI sector and increased cloud-compute spending. The stock had previously gained nearly 5% on Tuesday, influenced by analyst upgrades and the company's decision to raise GPU cloud prices by approximately 20% starting October 1. Over the past month, Nebius has seen a 13.47% increase, although it remains 19.9% below its June 52-week high of $299.86. https://openbell.ai/news/IQV:1790770752847 2026-09-30T12:19:12.847Z daily 0.9 https://cdn.brandfetch.io/IQV/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Reinstates Buy on IQVIA Holdings, Announces $345 Price Target UBS analyst Kevin Caliendo has reinstated a Buy rating on IQVIA Holdings (NYSE: IQV) and set a price target of $345 for the stock. This recommendation may influence investor sentiment and trading activity for IQVIA in the market. https://openbell.ai/news/MRK:1790770728412 2026-09-30T12:18:48.412Z daily 0.9 https://cdn.brandfetch.io/MRK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Merck’s Tulisokibart Meets Phase 2b Primary Endpoint In Hidradenitis Suppurativa, Achieves HiSCR50 of 72% And 64% Vs 35% for Placebo At Week 16 Merck (NYSE: MRK) announced that its investigational monoclonal antibody, tulisokibart, met the primary endpoint in a Phase 2b trial for treating moderate to severe hidradenitis suppurativa (HS). At week 16, 72% of patients in the high-dose group and 64% in the medium-dose group achieved Hidradenitis Suppurativa Clinical Response 50 (HiSCR50), significantly outperforming the 35% response in the placebo group. The study also indicated improvements in patient quality of life, with notable reductions in the Dermatology Life Quality Index (DLQI) for the high- and medium-dose cohorts compared to placebo. https://openbell.ai/news/GNRC:1790770669083 2026-09-30T12:17:49.083Z daily 0.9 https://cdn.brandfetch.io/GNRC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stifel Maintains Buy on Generac Holdings, Raises Price Target to $290 Stifel analyst Stephen Gengaro has maintained a 'Buy' rating on Generac Holdings (NYSE: GNRC) and increased the price target from $285 to $290. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/FRSX:1790770643668 2026-09-30T12:17:23.668Z daily 0.9 https://cdn.brandfetch.io/FRSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Foresight Autonomous Holdings Plans To Voluntarily Deslist Ordinary Shares From Tel Aviv Stock Exchange Foresight Autonomous Holdings Ltd. (Ticker: FRSX) has announced its decision to voluntarily delist its ordinary shares from the Tel Aviv Stock Exchange (TASE). The company specializes in 3D perception systems and is currently listed on both Nasdaq and TASE. https://openbell.ai/news/PSIX:1790770537627 2026-09-30T12:15:37.627Z daily 0.9 https://cdn.brandfetch.io/PSIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Power Solutions Enters Into Revolving Credit Agreement Permitting Borrowing Up To $220M Power Solutions has entered into a revolving credit agreement that allows for borrowing up to $220 million. This move was disclosed in a recent SEC filing. The agreement is expected to provide the company with increased financial flexibility. https://openbell.ai/news/HTLM:1790770387077 2026-09-30T12:13:07.077Z daily 0.9 https://cdn.brandfetch.io/HTLM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Homestolife Q2 EPS $0.03 Down From $0.08 YoY, Sales $105.775M Up From $101.289M YoY Homestolife (NASDAQ: HTLM) reported Q2 earnings of $0.03 per share, a 62.5% decrease from $0.08 per share year-over-year. The company's sales reached $105.775 million, marking a 4.43% increase from $101.289 million in the same quarter last year. https://openbell.ai/news/ABNB:1790770355076 2026-09-30T12:12:35.076Z daily 0.9 https://cdn.brandfetch.io/ABNB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Airbnb Introduces AI-Enabled Search, Filters, Listing Descriptions, Comparison Tools; Rolls Out Grocery Delivery Service In Europe; Launching Laundry Services In Specific U.S. Cities Airbnb has launched several new features including AI-enabled search, enhanced filters, improved listing descriptions, and comparison tools to enhance user experience. Additionally, the company is rolling out a grocery delivery service in Europe and is set to introduce laundry services in select U.S. cities. These strategic initiatives aim to expand Airbnb's service offerings and improve customer satisfaction. https://openbell.ai/news/TLIH:1790770280416 2026-09-30T12:11:20.416Z daily 0.9 https://cdn.brandfetch.io/TLIH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ten-League International H1 EPS $0.46 Down From $0.70 YoY, Sales $25.600M Down From $29.600M YoY Ten-League International (NASDAQ:TLIH) reported a first-half earnings per share (EPS) of $0.46, down 34.29% from $0.70 in the same period last year. The company's sales totaled $25.600 million, reflecting a 13.51% decrease from $29.600 million year-over-year.